Summit Therapeutics Inc.
SMMT stock score: 40/100
$15.55 · -1.77% · Scored Oct 22, 2026
- Technical
- 46
- Fundamental
- 33
- News
- 53
The reading
Summit Therapeutics (SMMT) scores 40 out of 100, which reads weak, higher than 33% of Healthcare stocks and 18% of the 4,161 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 46, fundamentals 33.
Among the fundamentals, Quick Ratio at 100 and Current Ratio at 100 score highest, while Earnings Quality (Annual) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 32 and contrarian oscillators 52.
News sentiment is neutral at 53; it is shown, not counted in the composite.
Since Jul 25, 2026 the composite has ranged from 36 to 53, and it is down 12 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward SMMT’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
33Pulling it up
- Quick Ratio100
Quick ratio measures a company's ability to meet short-term obligations with liquid assets.
- Current Ratio100
Current ratio measures ability to pay short-term liabilities with current assets.
- Insider Transactions100
Insider transactions track recent buying and selling by company insiders.
Holding it back
- Earnings Quality (Annual)0
Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.
- Earnings Growth (5-Year)0
5-year earnings growth evaluates long-term profit trajectory and consistency.
- Price to Book Ratio0
Price-to-Book ratio compares market value to book value.
30 weighted scorers; 11 had no data today and are left out rather than counted as zero.
Technical · daily
35Pulling it up
- SMA 100 Cross Up77
SMA 100 Cross Up identifies when shorter averages cross above the 100-period SMA.
- TRIX69
TRIX is a momentum oscillator that filters out short-term noise by triple-smoothing price data.
- Bollinger Bands (20)69
Bollinger Bands (20-period) plot standard deviations above and below a moving average.
Holding it back
- VWAP0
Volume Weighted Average Price (VWAP) shows the average price weighted by volume.
- Parabolic SAR (PSAR)0
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- SMA 20 Cross Up11
SMA 20 Cross Up tracks when very short-term averages cross above the 20-period SMA.
61 weighted scorers; 4 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 53
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 44 | 1 |
| Daily | 35 | 3 |
| Weekly | 45 | 2 |
| Monthly | 51 | 2 |
| Quarterly | 60 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 22, 2026 | 40 |
| Oct 21, 2026 | 43 |
| Oct 20, 2026 | 43 |
| Oct 19, 2026 | 41 |
| Oct 18, 2026 | 38 |
| Oct 17, 2026 | 38 |
| Oct 16, 2026 | 38 |
| Oct 15, 2026 | 39 |
| Oct 14, 2026 | 39 |
| Oct 13, 2026 | 41 |
| Oct 12, 2026 | 47 |
| Oct 11, 2026 | 47 |
| Oct 10, 2026 | 47 |
| Oct 9, 2026 | 48 |
| Oct 8, 2026 | 47 |
| Oct 7, 2026 | 48 |
| Oct 6, 2026 | 48 |
| Oct 5, 2026 | 48 |
| Oct 4, 2026 | 46 |
| Oct 3, 2026 | 46 |
| Oct 2, 2026 | 46 |
| Oct 1, 2026 | 47 |
| Sep 30, 2026 | 48 |
| Sep 29, 2026 | 47 |
| Sep 28, 2026 | 45 |
| Sep 27, 2026 | 43 |
| Sep 26, 2026 | 43 |
| Sep 25, 2026 | 43 |
| Sep 24, 2026 | 44 |
| Sep 23, 2026 | 46 |
| Sep 22, 2026 | 47 |
| Sep 21, 2026 | 48 |
| Sep 20, 2026 | 49 |
| Sep 19, 2026 | 49 |
| Sep 18, 2026 | 49 |
| Sep 17, 2026 | 49 |
| Sep 16, 2026 | 47 |
| Sep 15, 2026 | 48 |
| Sep 14, 2026 | 50 |
| Sep 13, 2026 | 49 |
| Sep 12, 2026 | 49 |
| Sep 11, 2026 | 49 |
| Sep 10, 2026 | 47 |
| Sep 9, 2026 | 49 |
| Sep 8, 2026 | 49 |
| Sep 7, 2026 | 48 |
| Sep 6, 2026 | 49 |
| Sep 5, 2026 | 49 |
| Sep 4, 2026 | 48 |
| Sep 3, 2026 | 48 |
| Sep 2, 2026 | 43 |
| Sep 1, 2026 | 42 |
| Aug 31, 2026 | 38 |
| Aug 30, 2026 | 40 |
| Aug 29, 2026 | 40 |
| Aug 28, 2026 | 40 |
| Aug 27, 2026 | 41 |
| Aug 26, 2026 | 42 |
| Aug 25, 2026 | 39 |
| Aug 24, 2026 | 36 |
| Aug 23, 2026 | 37 |
| Aug 22, 2026 | 38 |
| Aug 20, 2026 | 40 |
| Aug 19, 2026 | 42 |
| Aug 18, 2026 | 40 |
| Aug 17, 2026 | 40 |
| Aug 16, 2026 | 42 |
| Aug 15, 2026 | 42 |
| Aug 14, 2026 | 42 |
| Aug 13, 2026 | 44 |
| Aug 12, 2026 | 47 |
| Aug 11, 2026 | 47 |
| Aug 10, 2026 | 46 |
| Aug 9, 2026 | 44 |
| Aug 8, 2026 | 44 |
| Aug 7, 2026 | 44 |
| Aug 6, 2026 | 47 |
| Aug 5, 2026 | 46 |
| Aug 3, 2026 | 45 |
| Aug 2, 2026 | 42 |
| Jul 31, 2026 | 52 |
| Jul 30, 2026 | 51 |
| Jul 29, 2026 | 49 |
| Jul 28, 2026 | 52 |
| Jul 27, 2026 | 53 |
| Jul 26, 2026 | 52 |
| Jul 25, 2026 | 52 |
Key facts
- Market cap
- $12.4B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- -1.52
- Risk grade (1–10)
- 10
- Next earnings
- Oct 27, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| HALO Halozyme Therapeutics | $14.1B | 69 |
| JAZZ Jazz Pharmaceuticals | $13.9B | 57 |
| BBIO BridgeBio Pharma | $13.3B | 48 |
| CORT Corcept Therapeutics | $11.6B | 56 |
| TECH Bio-Techne | $11.4B | 58 |
| BMRN BioMarin Pharmaceutical | $11.0B | 47 |
Questions
What is SMMT's stock score today?
SMMT scores 40/100 (Weak) as of Oct 22, 2026: technical 46, fundamental 33, and news sentiment 53, which is shown but not counted. Scores are recomputed every night.
Is SMMT a buy?
The score is not a buy or sell recommendation. A 40 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the SMMT score calculated?
91 weighted scorers feed it today: 30 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.